{"id":768666,"date":"2023-07-10T14:51:39","date_gmt":"2023-07-10T18:51:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/"},"modified":"2023-07-10T14:51:39","modified_gmt":"2023-07-10T18:51:39","slug":"shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/","title":{"rendered":"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED)"},"content":{"rendered":"
\n

BALA CYNWYD, Pa., July 10, 2023 (GLOBE NEWSWIRE) — Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Amedisys, Inc. (\u201cAmedisys\u201d or the \u201cCompany\u201d) (Nasdaq \u2013 AMED) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Optum (\u201cOptum\u201d). Under the terms of the Agreement, Amedisys shareholders will only $101.00 per share in cash.<\/p>\n

The investigation concerns whether the Amedisys Board breached its fiduciary duties to shareholders by failing to conduct a fair process resulting in Optum paying less than full value for the Company.<\/p>\n

If you own shares of Amedisys stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, by email at clients@brodsky-smith.com<\/a>, visiting https:\/\/www.brodskysmith.com\/cases\/investigation-amedisys-inc-nasdaq-amed\/<\/a>, or calling tolling free 855-576-4847.<\/p>\n

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BALA CYNWYD, Pa., July 10, 2023 (GLOBE NEWSWIRE) — Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Amedisys, Inc. (\u201cAmedisys\u201d or the \u201cCompany\u201d) (Nasdaq \u2013 AMED) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Optum (\u201cOptum\u201d). Under the terms of the Agreement, Amedisys shareholders will only $101.00 per share in cash. The investigation concerns whether the Amedisys Board breached its fiduciary duties to shareholders by failing to conduct a fair process resulting in Optum paying less than full value for the Company. If you own shares of Amedisys stock and wish to discuss the … <\/p>\n

Continue reading “SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-768666","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., July 10, 2023 (GLOBE NEWSWIRE) — Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Amedisys, Inc. (\u201cAmedisys\u201d or the \u201cCompany\u201d) (Nasdaq \u2013 AMED) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Optum (\u201cOptum\u201d). Under the terms of the Agreement, Amedisys shareholders will only $101.00 per share in cash. The investigation concerns whether the Amedisys Board breached its fiduciary duties to shareholders by failing to conduct a fair process resulting in Optum paying less than full value for the Company. If you own shares of Amedisys stock and wish to discuss the … Continue reading "SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-10T18:51:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED)\",\"datePublished\":\"2023-07-10T18:51:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/\"},\"wordCount\":260,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/\",\"name\":\"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg=\",\"datePublished\":\"2023-07-10T18:51:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/","og_locale":"en_US","og_type":"article","og_title":"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., July 10, 2023 (GLOBE NEWSWIRE) — Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Amedisys, Inc. (\u201cAmedisys\u201d or the \u201cCompany\u201d) (Nasdaq \u2013 AMED) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Optum (\u201cOptum\u201d). Under the terms of the Agreement, Amedisys shareholders will only $101.00 per share in cash. The investigation concerns whether the Amedisys Board breached its fiduciary duties to shareholders by failing to conduct a fair process resulting in Optum paying less than full value for the Company. If you own shares of Amedisys stock and wish to discuss the … Continue reading \"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-10T18:51:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED)","datePublished":"2023-07-10T18:51:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/"},"wordCount":260,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/","name":"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg=","datePublished":"2023-07-10T18:51:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MTc3NSM1Njg0ODQzIzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-notice-brodsky-smith-announces-an-investigation-of-amedisys-inc-nasdaq-amed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq \u2013 AMED)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/768666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=768666"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/768666\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=768666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=768666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=768666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}